Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07490444 · ClinicalTrials.gov registry record · Phase 2
Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome
A Phase 2 study, sponsored by Ohio State University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT07490444: Recruiting Phase 2 study, sponsored by Ohio State University.
NCT07490444 is a Phase 2 study that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 24 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07490444, a Phase 2 study, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study seeks to determine whether glasses prescriptions determined from computer analysis of detailed images of the eyes provide better vision outcomes for children with Down syndrome than prescriptions determined using routine clinical methods.
Primary Outcome
Aided LogMAR (minimum angle of resolution) distance visual acuity obtained with either British Standard Letters or HOTV - matching for participants unable to name letters
Interventions
- DEVICE Metric-optimized spectacles
- DEVICE Routine Clinical Spectacles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-05-26 |
| Est. Completion | 2028-05-01 |
| Phase | Phase 2 |
What NCT07490444 shows while recruiting
NCT07490444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Metric-optimized spectacles is the first listed.
NCT07490444 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07490444 about?
NCT07490444 is a clinical study titled "Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome". This study seeks to determine whether glasses prescriptions determined from computer analysis of detailed images of the eyes provide better vision outcomes for children with Down syndrome than prescriptions determined using routine clinical methods.
What is the current status of trial NCT07490444?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2026-05-26. Estimated completion is 2028-05-01.
What interventions are being tested in trial NCT07490444?
The interventions under investigation include: Metric-optimized spectacles (DEVICE), Routine Clinical Spectacles (DEVICE).
Who is sponsoring clinical trial NCT07490444?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07490444's enrollment target sits among peer trials
24 1756th of 2000 higher than 217 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI